3KB-12031-85901
3 vaccinations
1 coded response
37 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 984 / WA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-19
- 2021-03-24
- 2021-03-31
- 2021-04-07
-
2021-04-10
Dose 2 — Pfizer-BioNTech
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-15
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-07-10
- 2021-10-09
-
2021-11-19
Dose 3 — Pfizer-BioNTech
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-12-03
- 2021-12-12
- 2021-12-19
- 2021-12-26
- 2021-12-31
- 2022-02-18
-
2022-05-20
Survey response — 6 months, dose 3MedDRA: Blood pressure increased, Hospitalisation, Pre-eclampsia, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Preeclampsia at 41.5 weeks pregnant · Healthcare visit (other): Had to stay in the hospital for extra 2 days because of high blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-05-23
-
2022-05-23
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-20 | Successful 2022-05-23 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 6 months, dose 3
Symptoms: Preeclampsia at 41.5 weeks pregnant
Healthcare visit (other): Had to stay in the hospital for extra 2 days because of high blood pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Blood pressure increased | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release